EMA To Restart Landmark Clinical Trial Transparency Policy In September

 
• By Vibha Sharma

The European Medicines Agency is preparing to resume proactively publishing clinical trial data submitted by companies to support their marketing authorization applications for non-COVID-19 products.

A businessman in formal wear signing a contract. Padlock Hologram icons over the working desk.
Business and personal information is reacted from clinical trial data before publication • Source: Shutterstock

More from Europe

More from Geography